Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Neurim Pharmaceuticals Ltd.

Clinical trials sponsored by Neurim Pharmaceuticals Ltd., explained in plain language.

Randomized, delayed start, double blind, parallel group, placebo controlled, multicenter study of piromelatine 20 mg in participants with mild dementia due to Alzheimer's disease

Stopped early

Randomized efficacy and safety study of piromelatine 20 mg versus placebo in participants with mild dementia due to Alzheimer's disease (AD) who are 2:107,510,000-107,540,000 polymorphism non-carriers with the primary objective to compare the effect of piromelatine to that of pla…

Phase 2/3 • Sponsor: Neurim Pharmaceuticals Ltd.

Last updated Sep 09, 2026 15:00 UTC